기업조회

본문 바로가기 주메뉴 바로가기

논문 기본정보

Nucleotide Variability in Enhancer 1 and Pre-X Promotor Regions of Hepatitis B Virus from Patients with Chronic Hepatitis B Virus Infection

논문 개요

기관명, 저널명, ISSN, ISBN 으로 구성된 논문 개요 표입니다.
기관명 NDSL
저널명 대한소화기학회지 = The Korean journal of gastroenterology
ISSN 1598-9992,
ISBN

논문저자 및 소속기관 정보

저자, 소속기관, 출판인, 간행물 번호, 발행연도, 초록, 원문UR, 첨부파일 순으로 구성된 논문저자 및 소속기관 정보표입니다
저자(한글) Song, Woo Kern,Kim, Haak Cheoul,Park, Do Sim,Cho, Ji Hyun
저자(영문)
소속기관
소속기관(영문)
출판인
간행물 번호
발행연도 2003-01-01
초록 BACKGROUND/AIMS: Hepatitis B Virus (HBV) is a compact DNA virus with four genes which are controlled by 6 promotors and two enhancers during its replication. However, HBV has variability in its nucleotide sequence and thus, it can be classified into genotypes. Recently, it is suggested that nucleotide mutations in its sequence are related to chronic liver disease (CLD). Therefore, we analyzed relationships between mutations and disease severity in its Enh 1 and X-promoter regions (1021-1373). METHODS: HBV DNA of the patients with chronic hepatitis (CH, n=30), liver cirrhosis (LC, n=25), and hepatocellular carcinoma (HCC, n=17) was amplified and sequenced. Then, we constructed a phylogenetic tree (PAUP4.0) and analyzed their mutation rates and specificity among the disease groups. RESULTS: All analyzed sequences belonged to genotype C. The divergency rate was 1.71% and there was no difference in their mutation rates, but there were some hot-spots among the disease groups. The hot-spots were at nucleotides 1317, 1229, 1126, 1134, and 1041 in decreasing order. Between the groups of LC and HCC, there were higher mutation rates at nucleotides 1126 (A- gt;C) and 1134 (T- gt;C) in LC, and at nucleotides 1229 (G- gt;A) and 1317 (A- gt;G) in HCC. The mutations at nucleotides 1126 and 1134 (p
원문URL http://click.ndsl.kr/servlet/OpenAPIDetailView?keyValue=03553784&target=NART&cn=NART48216790
첨부파일

추가정보

과학기술표준분류, ICT 기술분류,DDC 분류,주제어 (키워드) 순으로 구성된 추가정보표입니다
과학기술표준분류
ICT 기술분류
DDC 분류
주제어 (키워드) Hepatitis B virus,Enh 1,X-promotor,Nucleotide mutation,Hot-spot